Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma.
British Journal of Haematology.
Times cited: 5
High-quality cancer care: Summary of an institute of medicine workshop.
Journal of Oncology Practice.
Times cited: 2